Biologic Medicines & Production Tools

This basket focuses on companies whose businesses center on therapeutic proteins, antibodies, or RNA medicines, alongside a supplier supporting their development and production. The opportunity is to own established biological treatment franchises and the infrastructure needed to commercialize them, rather than a general drugmaker or obesity-only basket. Tonight's selection emphasizes existing products and manufacturing capabilities rather than relying on a new policy announcement or a single clinical readout. Launch basket (equal weight): AMGN, ABBV, LLY, MRNA, TMO, REGN, ALNY, BMRN Rules: 1. No inverse, leveraged or volatility ETFs. 2. Only names tradable at the enrolled brokers (Moomoo): no OTC listings, no dead tickers, nothing on the refused list.